Shan Huang

Shan Huang

Auto-generated profile, based on publicly available information

Shan Huang

Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Department of GI Medical Oncology, Tianjin Medical University Cancer Institute and Hospital, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2021 in Science Signaling
Verified
Journal Article
Closed access
PDF file
SHShan Huang
Shan Huang
ZLZexing Li
Zexing Li
ZWZewen Wu
Zewen Wu
CLChang Liu
Chang Liu
MYMinghang Yu
Minghang Yu
XWXi Wang
Xi Wang
DDAH2 inhibits antiviral signaling by promoting mitochondrial fission.

30 April 2021 in Cardiovascular Toxicology
Verified
Journal Article
Closed access
PDF file
SGShanquan Gao
Shanquan Gao
GGuoqi Li
Guoqi Li
YSYihui Shao
Yihui Shao
ZWZhipeng Wei
Zhipeng Wei
SHShan Huang
Shan Huang
JDJie Du
Jie Du

9 April 2025 in Science Translational Medicine
Verified
Journal Article
Closed access
XWXiaoqiang Wang
Xiaoqiang Wang
JJJiaxing Jin
Jiaxing Jin
HYHan Yan
Han Yan
JLJinhua Liu
Jinhua Liu
SHShan Huang
Shan Huang
DHDeqing Hu
Deqing Hu
Nuclear retroelement transcripts (RTs), which can be elicited both transcriptionally and posttranscriptionally, form double-stranded RNA (dsRNA) in cytosol to trigger the viral mimicry response (VMR) and antitumor immunity. However, the strength of the induced VMR varies tremendously across tumor types, and the underlying mechanisms remain poorly understood. Here, we demonstrate that the mRNA export pathway modulates the VMR through actively exporting nuclear RTs for cytosolic dsRNA formation after their induction. Tumor cells hijack this process for immune evasion through aberrant coactivator-associated arginine methyltransferase 1 (CARM1) expression. Mechanistically, we show that the cytoplasmic transportation of RTs by the mRNA export pathway is counteracted by the RNA exosome, which cleaves multiple transcripts within this pathway, including those encoding the essential DExD-box helicase 39A (DDX39A) and the adaptor protein ALYREF. CARM1 enhances the RNA exosome activity to attenuate the nuclear export of RTs by the mRNA export pathway through two synergistic mechanisms: (i) transcriptionally activating several RNA exosome components and (ii) posttranslationally methylating arginine 6 of the RNA exosome subunit EXOSC1, which protects it from proteasome-mediated degradation. Collectively, our study highlights the critical active regulatory role of the mRNA export pathway in transporting nuclear RTs into the cytosol for triggering the VMR and tumor immunity. Furthermore, we propose that enhancing the mRNA export pathway activity, either through CARM1 inhibition or RNA exosome modulation, could reinforce the therapeutic agent-induced VMR, thus holding the promise for overcoming tumor immune evasion and immunotherapy resistance.